Gold, you stated, "Half, if RECAF could generate 1 billion in sales, Abbott would have been falling all over themselves to continue developing the test. They are not."
First, go back 4 or 5 years. All Abbott invested in was a radioisotope. I don't have to list all the accomplishments Dr Moro has accomplished with recaf since he started. He himself did not know that recaf can detect EARLY cancer, it shows up in saliva, and in urine, and in different species other than human. We sold a prototype. A first generation recaf persay, and now it has evolved into a lucrative biomarker capable of cancer detection like no other marker out there. I would say Abbott is NOT stupid. They ARE on board.
Second, Half was speaking about POTENTIAL earnings. Well, I am not going to say he is correct or incorrect in his assumption of a billion in sales. What small thing he and you overlooked was that the share price you both calculated was not taking into consideration the share price would have to have a multiple (a P/E ratio). Now go back and figure the share price with a 5-10 P/E multiple. The share price becomes 5-10 times GREATER than you both were calculating. Now how do you like them apples? Still think this will not be a huge return on your money. Coulda, woulda, shoulda.
News 
Market Data 
Discover 
AI
